{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T14:38:17Z","timestamp":1794926297223,"version":"4.9.1"},"reference-count":256,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023731","name":"Regional Government of Andalusia Ministry of Health and Consumer Affairs","doi-asserted-by":"publisher","award":["PY20\/01282"],"award-info":[{"award-number":["PY20\/01282"]}],"id":[{"id":"10.13039\/501100023731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI20\/01845"],"award-info":[{"award-number":["PI20\/01845"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["DTS23\/00030"],"award-info":[{"award-number":["DTS23\/00030"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI17\/02256"],"award-info":[{"award-number":["PI17\/02256"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.biopha.2026.119394","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T19:59:27Z","timestamp":1776715167000},"page":"119394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Non-coding RNAs as biomarkers and therapeutic targets in pancreatic cancer: Clinical implications and translational perspectives"],"prefix":"10.1016","volume":"199","author":[{"given":"Mar\u00eda","family":"Carretero-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Ru\u00edz-Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Uysal-Onganer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Yiannakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bur\u00e7ak","family":"Otlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Jos\u00e9","family":"Garc\u00eda-Verdejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"L\u00f3pez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Gabriel","family":"Ortega S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bonilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Mesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Reyes-Zurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Francisco","family":"Guti\u00e9rrez-Bautista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Gonz\u00e1lez-Olmedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn A.","family":"Fern\u00e1ndez-Baldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Campa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"S\u00e1nchez-Rovira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Jos\u00e9","family":"Cabrera-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9355-2423","authenticated-orcid":false,"given":"Juan","family":"Sainz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-018-4610-4","article-title":"Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; A SEER-based study","volume":"18","author":"Saad","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2026.119394_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104020","article-title":"The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years\u2019 experience of association studies to understand the genetic architecture of pancreatic cancer","volume":"186","author":"Campa","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.biopha.2026.119394_bib3","article-title":"KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression","volume":"11","author":"Zhang","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"19","key":"10.1016\/j.biopha.2026.119394_bib4","article-title":"The heterogeneity of the tumor microenvironment as essential determinant of development, progression and therapy response of pancreatic cancer","volume":"13","author":"Aldag","year":"2021","journal-title":"Cancers"},{"issue":"18","key":"10.1016\/j.biopha.2026.119394_bib5","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.3748\/wjg.v28.i18.1934","article-title":"Targeting pancreatic cancer immune evasion by inhibiting histone deacetylases","volume":"28","author":"Sim","year":"2022","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119394_bib6","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1261\/rna.037424.112","article-title":"Multiple sensors ensure guide strand selection in human RNAi pathways","volume":"19","author":"Noland","year":"2013","journal-title":"RNA"},{"issue":"4","key":"10.1016\/j.biopha.2026.119394_bib7","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1101\/gr.139758.112","article-title":"Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation","volume":"23","author":"Hausser","year":"2013","journal-title":"Genome Res"},{"issue":"7149","key":"10.1016\/j.biopha.2026.119394_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature05983","article-title":"Intronic microRNA precursors that bypass Drosha processing","volume":"448","author":"Ruby","year":"2007","journal-title":"Nature"},{"issue":"34","key":"10.1016\/j.biopha.2026.119394_bib9","doi-asserted-by":"crossref","first-page":"15163","DOI":"10.1073\/pnas.1006432107","article-title":"Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.biopha.2026.119394_bib10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.molcel.2007.02.011","article-title":"P Bodies and the control of mRNA Translation and Degradation","volume":"25","author":"Parker","year":"2007","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-016-0319-x","article-title":"Dysregulation of microRNA biogenesis in cancer: The impact of mutant p53 on Drosha complex activity","volume":"35","author":"Gurtner","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2026.119394_bib12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding RNAs: definitions, functions, challenges and recommendations","volume":"24","author":"Mattick","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"13","key":"10.1016\/j.biopha.2026.119394_bib13","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/onc.2012.193","article-title":"HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer","volume":"32","author":"Kim","year":"2012","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.gpb.2015.09.006","article-title":"Roles, functions, and mechanisms of long non-coding RNAs in cancer","volume":"14","author":"Fang","year":"2016","journal-title":"Genom. Proteom. Bioinforma."},{"key":"10.1016\/j.biopha.2026.119394_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.714768","article-title":"From Junk to Function: LncRNAs in CNS Health and Disease","volume":"14","author":"Policarpo","year":"2021","journal-title":"Front Mol. Neurosci."},{"key":"10.1016\/j.biopha.2026.119394_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.670719","article-title":"Emerging classes of small non-coding RNAs with potential implications in diabetes and associated metabolic disorders","volume":"12","author":"Jacovetti","year":"2021","journal-title":"Front Endocrinol."},{"key":"10.1016\/j.biopha.2026.119394_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fpls.2020.526455","article-title":"siRNA Specificity: RNAi Mechanisms and Strategies to Reduce Off-Target Effects","volume":"11","author":"Neumeier","year":"2021","journal-title":"Front Plant Sci."},{"issue":"9","key":"10.1016\/j.biopha.2026.119394_bib18","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1080\/15476286.2016.1259781","article-title":"Tuning the ribosome: The influence of rRNA modification on eukaryotic ribosome biogenesis and function","volume":"14","author":"Sloan","year":"2017","journal-title":"RNA Biol."},{"key":"10.1016\/j.biopha.2026.119394_bib19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-94-017-7417-8_4","article-title":"The piRNA pathway guards the germline genome against transposable elements","volume":"886","author":"T\u00f3th","year":"2016","journal-title":"Adv. Exp. Med Biol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119394_bib20","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/s41556-021-00746-2","article-title":"Formation of spermatogonia and fertile oocytes in golden hamsters requires piRNAs","volume":"23","author":"Loubalova","year":"2021","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib21","first-page":"1","article-title":"Insights into the role of hnRNPK in spermatogenesis via the piRNA pathway","volume":"15","author":"Xu","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2026.119394_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3748\/wjg.v30.i2.115","article-title":"Small nucleolar RNA and its potential role in the oncogenesis and development of colorectal cancer","volume":"30","author":"Lan","year":"2024","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119394_bib23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0092-8674(00)80156-7","article-title":"The RNA world of the nucleolus: Two major families of small RNAs defined by different box elements with related functions","volume":"86","author":"Balakin","year":"1996","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biopha.2026.119394_bib24","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/15476286.2016.1243646","article-title":"Assembly and trafficking of box C\/D and H\/ACA snoRNPs","volume":"14","author":"Massenet","year":"2016","journal-title":"RNA Biol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119394_bib25","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.bbagrm.2014.04.009","article-title":"The many faces of small nucleolar RNAs","volume":"1839","author":"Bratkovi\u010d","year":"2014","journal-title":"Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"},{"issue":"15","key":"10.1016\/j.biopha.2026.119394_bib26","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3390\/cells11152374","article-title":"MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions","volume":"11","author":"Prinz","year":"2022","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.biopha.2026.119394_bib27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.21873\/cgp.20149","article-title":"Pancreatic Ductal Adenocarcinoma: MicroRNAs Affecting Tumor Growth and Metastasis in Preclinical In Vivo Models","volume":"16","author":"Weidle","year":"2019","journal-title":"Cancer Genom. Proteom."},{"issue":"11","key":"10.1016\/j.biopha.2026.119394_bib28","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3390\/cells13110948","article-title":"The Multifaceted Role of miR-21 in Pancreatic Cancers","volume":"13","author":"Chen","year":"2024","journal-title":"Cells"},{"issue":"48","key":"10.1016\/j.biopha.2026.119394_bib29","doi-asserted-by":"crossref","first-page":"80033","DOI":"10.18632\/oncotarget.12406","article-title":"New combined microRNA and protein plasmatic biomarker panel for pancreatic cancer","volume":"7","author":"Yuan","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.biopha.2026.119394_bib30","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7150\/ijbs.15017","article-title":"MicroRNA targeted therapeutic approach for pancreatic cancer","volume":"12","author":"Li","year":"2016","journal-title":"Int J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2026.119394_bib31","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/cam4.626","article-title":"MicroRNA-21 induces 5-fluorouracil resistance in human pancreatic cancer cells by regulating PTEN and PDCD4","volume":"5","author":"Wei","year":"2016","journal-title":"Cancer Med"},{"issue":"11","key":"10.1016\/j.biopha.2026.119394_bib32","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1158\/0008-5472.CAN-09-4467","article-title":"MicroRNA-21 in pancreatic cancer: Correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity","volume":"70","author":"Giovannetti","year":"2010","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000231984","article-title":"Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma","volume":"10","author":"Ryu","year":"2010","journal-title":"Pancreatology"},{"issue":"3","key":"10.1016\/j.biopha.2026.119394_bib34","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3892\/or.2013.2576","article-title":"Regulation of miR-155 affects pancreatic cancer cell invasiveness and migration by modulating the STAT3 signaling pathway through SOCS1","volume":"30","author":"Huang","year":"2013","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ijc.24687","article-title":"Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival","volume":"126","author":"Greither","year":"2010","journal-title":"Int J. Cancer"},{"issue":"9","key":"10.1016\/j.biopha.2026.119394_bib36","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.3390\/cancers17091586","article-title":"Unraveling Venetoclax Resistance: Navigating the Future of HMA\/Venetoclax-Refractory AML in the Molecular Era","volume":"17","author":"Chatzilygeroudi","year":"2025","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.biopha.2026.119394_bib37","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1073\/pnas.0610731104","article-title":"MicroRNA-155 is induced during the macrophage inflammatory response","volume":"104","author":"O\u2019Connell","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.biopha.2026.119394_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010630","article-title":"Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer","volume":"5","author":"Hwang","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2026.119394_bib39","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s10620-010-1285-3","article-title":"Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis","volume":"56","author":"Kong","year":"2011","journal-title":"Dig. Dis. Sci."},{"issue":"13","key":"10.1016\/j.biopha.2026.119394_bib40","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1158\/1078-0432.CCR-12-3092","article-title":"MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls","volume":"19","author":"Li","year":"2013","journal-title":"Clin. Cancer Res"},{"issue":"17","key":"10.1016\/j.biopha.2026.119394_bib41","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.297.17.1901","article-title":"MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis","volume":"297","author":"Bloomston","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib42","first-page":"28","article-title":"Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer","volume":"3","author":"Ali","year":"2010","journal-title":"Am. J. Transl. Res"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib43","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1080\/21655979.2021.1956404","article-title":"The clinical significance of microRNA-409 in pancreatic carcinoma and associated tumor cellular functions","volume":"12","author":"Long","year":"2021","journal-title":"Bioengineered"},{"issue":"17","key":"10.1016\/j.biopha.2026.119394_bib44","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1158\/1078-0432.CCR-12-0035","article-title":"miRNA Biomarkers in Cyst Fluid Augment the Diagnosis and Management of Pancreatic Cysts","volume":"18","author":"Matthaei","year":"2012","journal-title":"Clin. Cancer Res"},{"issue":"3","key":"10.1016\/j.biopha.2026.119394_bib45","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.7150\/ijbs.67675","article-title":"Hypoxic pancreatic cancer derived exosomal miR-30b-5p promotes tumor angiogenesis by inhibiting GJA1 expression","volume":"18","author":"Chen","year":"2022","journal-title":"Int J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib46","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41467-019-08759-0","article-title":"MiR-135 suppresses glycolysis and promotes pancreatic cancer cell adaptation to metabolic stress by targeting phosphofructokinase-1","volume":"10","author":"Yang","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib47","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/s12935-022-02835-0","article-title":"Increased expression of miR-194-5p through the circPVRL3\/miR-194-5p\/SOCS2 axis promotes proliferation and metastasis in pancreatic ductal adenocarcinoma by activating the PI3K\/AKT signaling pathway","volume":"22","author":"Chi","year":"2022","journal-title":"Cancer Cell Int"},{"issue":"4","key":"10.1016\/j.biopha.2026.119394_bib48","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/carcin\/bgx013","article-title":"MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer","volume":"38","author":"Kanno","year":"2017","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.biopha.2026.119394_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087897","article-title":"MiR-196a Promotes Pancreatic Cancer Progression by Targeting Nuclear Factor Kappa-B-Inhibitor Alpha","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.biopha.2026.119394_bib50","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1002\/1878-0261.70048","article-title":"MicroRNA 196a contributes to the aggressiveness of esophageal adenocarcinoma through the MYC\/TERT\/NF\u03baB axis","volume":"19","author":"Garc\u00eda-Castillo","year":"2025","journal-title":"Mol. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119394_bib51","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.pan.2016.05.005","article-title":"Serum microRNA-196 and microRNA-200 in pancreatic ductal adenocarcinoma of patients with diabetes mellitus","volume":"16","author":"\u0160krha","year":"2016","journal-title":"Pancreatology"},{"key":"10.1016\/j.biopha.2026.119394_bib52","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-8-266","article-title":"Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres","volume":"8","author":"Ji","year":"2008","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib53","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.canlet.2013.10.009","article-title":"MiR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression","volume":"344","author":"Guo","year":"2014","journal-title":"Cancer Lett."},{"issue":"44","key":"10.1016\/j.biopha.2026.119394_bib54","doi-asserted-by":"crossref","first-page":"71635","DOI":"10.18632\/oncotarget.11928","article-title":"Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential","volume":"7","author":"Kwon","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.biopha.2026.119394_bib55","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/carcin\/bgq160","article-title":"The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS","volume":"31","author":"Zhao","year":"2010","journal-title":"Carcinogenesis"},{"issue":"11","key":"10.1016\/j.biopha.2026.119394_bib56","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1158\/1535-7163.MCT-13-0296","article-title":"miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4","volume":"12","author":"Zhao","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2026.119394_bib57","article-title":"Biological Functions and Molecular Mechanisms of MiR-608 in Cancer","volume":"12","author":"Lu","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2026.119394_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.625056","article-title":"MicroRNA-505, Suppressed by Oncogenic Long Non-coding RNA LINC01448, Acts as a Novel Suppressor of Glycolysis and Tumor Progression Through Inhibiting HK2 Expression in Pancreatic Cancer","volume":"8","author":"Xu","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib59","article-title":"miR-34a inhibits pancreatic cancer progression through Snail1-mediated epithelial\u2013mesenchymal transition and the Notch signaling pathway","volume":"7","author":"Tang","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.biopha.2026.119394_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006816","article-title":"MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells","volume":"4","author":"Ji","year":"2009","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.biopha.2026.119394_bib61","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1158\/1535-7163.MCT-11-0152","article-title":"Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice","volume":"10","author":"Pramanik","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2026.119394_bib62","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1756-8722-3-46","article-title":"Dysregulation of miR-15a and miR-214 in human pancreatic cancer","volume":"3","author":"Zhang","year":"2010","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2026.119394_bib63","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.omtn.2019.11.010","article-title":"Functional Significance and Therapeutic Potential of miR-15a Mimic in Pancreatic Ductal Adenocarcinoma","volume":"19","author":"Guo","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41392-024-01740-4","article-title":"Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma","volume":"9","author":"Rampioni Vinciguerra","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"11","key":"10.1016\/j.biopha.2026.119394_bib65","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1002\/ijc.31654","article-title":"MiR-29a, targeting caveolin 2 expression, is responsible for limitation of pancreatic cancer metastasis in patients with normal level of serum CA125","volume":"143","author":"Liang","year":"2018","journal-title":"Int J. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/srep11450","article-title":"Pathophysiological role of microRNA-29 in pancreatic cancer stroma","volume":"5","author":"Kwon","year":"2015","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.biopha.2026.119394_bib67","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.149539","article-title":"Loss of miR-29a\/b1 promotes inflammation and fibrosis in acute pancreatitis","volume":"6","author":"Dey","year":"2021","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.biopha.2026.119394_bib68","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.21037\/tcr.2020.02.24","article-title":"LncRNA FAM66C inhibits pancreatic cancer progression by sponging miR-574-3p","volume":"9","author":"Zhu","year":"2020","journal-title":"Transl. Cancer Res"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib69","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/cas.14232","article-title":"Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer","volume":"111","author":"Takahashi","year":"2020","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.biopha.2026.119394_bib70","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.3892\/or.2014.3518","article-title":"Elevated expression level of long noncoding RNA MALAT-1 facilitates cell growth, migration and invasion in pancreatic cancer","volume":"32","author":"Jiao","year":"2014","journal-title":"Oncol. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2026.119394_bib71","doi-asserted-by":"crossref","first-page":"11194","DOI":"10.18632\/oncotarget.7156","article-title":"EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer","volume":"7","author":"Han","year":"2016","journal-title":"Oncotarget"},{"issue":"13","key":"10.1016\/j.biopha.2026.119394_bib72","doi-asserted-by":"crossref","first-page":"10840","DOI":"10.18632\/oncotarget.3450","article-title":"The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration","volume":"6","author":"Cheng","year":"2015","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.biopha.2026.119394_bib73","doi-asserted-by":"crossref","first-page":"9163","DOI":"10.1007\/s13277-014-2185-5","article-title":"H19 promotes pancreatic cancer metastasis by derepressing let-7\u2019s suppression on its target HMGA2-mediated EMT","volume":"35","author":"Ma","year":"2014","journal-title":"Tumour Biol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119394_bib74","doi-asserted-by":"crossref","DOI":"10.1111\/boc.202400034","article-title":"LncRNA HULC augments high glucose-associated pancreatic cancer progression and drug resistance by enhancing YAP activity and autophagy","volume":"116","author":"Sharma","year":"2024","journal-title":"Biol. Cell"},{"key":"10.1016\/j.biopha.2026.119394_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01013","article-title":"The Interaction Between Long Non-coding RNA HULC and MicroRNA-622 via Transfer by Extracellular Vesicles Regulates Cell Invasion and Migration in Human Pancreatic Cancer","volume":"10","author":"Takahashi","year":"2020","journal-title":"Front Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119394_bib76","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.18632\/aging.203903","article-title":"LncRNA HULC as a potential predictor of prognosis and clinicopathological features in patients with digestive system tumors: a meta-analysis","volume":"14","author":"Li","year":"2022","journal-title":"Aging"},{"issue":"6","key":"10.1016\/j.biopha.2026.119394_bib77","article-title":"Molecular anatomy of the architectural NEAT1 noncoding RNA: The domains, interactors, and biogenesis pathway required to build phase-separated nuclear paraspeckles","volume":"10","author":"Hirose","year":"2019","journal-title":"Wiley Inter. Rev. RNA"},{"key":"10.1016\/j.biopha.2026.119394_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00309","article-title":"Non-coding RNAs in Pancreatic Ductal Adenocarcinoma","volume":"10","author":"Gong","year":"2020","journal-title":"Front Oncol."},{"issue":"21","key":"10.1016\/j.biopha.2026.119394_bib79","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.18632\/aging.102417","article-title":"Emerging roles of piRNAs in cancer: challenges and prospects","volume":"11","author":"Cheng","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"13","key":"10.1016\/j.biopha.2026.119394_bib80","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/onc.2012.193","article-title":"HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer","volume":"32","author":"Kim","year":"2013","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.biopha.2026.119394_bib81","first-page":"2638","article-title":"Downregulation of NUF2 inhibits tumor growth and induces apoptosis by regulating lncRNA AF339813","volume":"8","author":"Hu","year":"2015","journal-title":"Int J. Clin. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib82","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-017-0192-0","article-title":"Long non-coding RNA GAS5 suppresses pancreatic cancer metastasis through modulating miR-32-5p\/PTEN axis","volume":"7","author":"Gao","year":"2017","journal-title":"Cell Biosci."},{"issue":"4","key":"10.1016\/j.biopha.2026.119394_bib83","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1002\/jcp.29288","article-title":"LINC01559 accelerates pancreatic cancer cell proliferation and migration through YAP-mediated pathway","volume":"235","author":"Lou","year":"2020","journal-title":"J. Cell Physiol."},{"issue":"14","key":"10.1016\/j.biopha.2026.119394_bib84","doi-asserted-by":"crossref","first-page":"14452","DOI":"10.18632\/aging.103487","article-title":"Long noncoding RNA LINC01559 promotes pancreatic cancer progression by acting as a competing endogenous RNA of miR-1343-3p to upregulate RAF1 expression","volume":"12","author":"Chen","year":"2020","journal-title":"Aging"},{"issue":"7","key":"10.1016\/j.biopha.2026.119394_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-024-06876-3","article-title":"LINC01133 promotes pancreatic ductal adenocarcinoma epithelial\u2013mesenchymal transition mediated by SPP1 through binding to Arp3","volume":"15","author":"Yang","year":"2024","journal-title":"Cell Death & Dis."},{"issue":"5","key":"10.1016\/j.biopha.2026.119394_bib86","first-page":"2358","article-title":"Clinical significance of CA 19.9 and LINC01197 in pancreatic cancer","volume":"24","author":"Jia","year":"2020","journal-title":"Eur. Rev. Med Pharm. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1174-3","article-title":"FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt\/\u03b2-catenin signaling","volume":"38","author":"Ling","year":"2019","journal-title":"J. Exp. & Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119394_bib88","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canlet.2018.12.017","article-title":"Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8","volume":"446","author":"Chen","year":"2019","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.biopha.2026.119394_bib89","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.1111\/jcmm.14467","article-title":"LncRNA SNHG14 potentiates pancreatic cancer progression via modulation of annexin A2 expression by acting as a competing endogenous RNA for miR-613","volume":"23","author":"Deng","year":"2019","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.biopha.2026.119394_bib90","article-title":"LncRNA SNHG1 Promotes the Progression of Pancreatic Cancer by Regulating FGFR1 Expression via Competitively Binding to miR-497","volume":"12","author":"Chen","year":"2022","journal-title":"Front Oncol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119394_bib91","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/bjc.2014.520","article-title":"A novel long non-coding RNA ENST00000480739 suppresses tumour cell invasion by regulating OS-9 and HIF-1\u03b1 in pancreatic ductal adenocarcinoma","volume":"111","author":"Sun","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2026.119394_bib92","doi-asserted-by":"crossref","first-page":"14929","DOI":"10.1007\/s13277-016-5380-8","article-title":"Long non-coding RNA IRAIN suppresses apoptosis and promotes proliferation by binding to LSD1 and EZH2 in pancreatic cancer","volume":"37","author":"Lian","year":"2016","journal-title":"Tumour Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2011.02.027","article-title":"Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells","volume":"407","author":"You","year":"2011","journal-title":"Biochem Biophys. Res Commun."},{"issue":"18","key":"10.1016\/j.biopha.2026.119394_bib94","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00125-17","article-title":"Long Noncoding RNA JHDM1D-AS1 Promotes Tumor Growth by Regulating Angiogenesis in Response to Nutrient Starvation","volume":"37","author":"Kondo","year":"2017","journal-title":"Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119394_bib95","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bbrc.2016.11.120","article-title":"Long non-coding RNA NEAT1 facilitates pancreatic cancer progression through negative modulation of miR-506-3p","volume":"482","author":"Huang","year":"2017","journal-title":"Biochem Biophys. Res Commun."},{"issue":"22","key":"10.1016\/j.biopha.2026.119394_bib96","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00278-17","article-title":"Long Noncoding RNA MEG3 Is an Epigenetic Determinant of Oncogenic Signaling in Functional Pancreatic Neuroendocrine Tumor Cells","volume":"37","author":"Iyer","year":"2017","journal-title":"Mol. Cell Biol."},{"issue":"51","key":"10.1016\/j.biopha.2026.119394_bib97","doi-asserted-by":"crossref","first-page":"89149","DOI":"10.18632\/oncotarget.20803","article-title":"Meta-analysis of the clinical value of abnormally expressed long non-coding RNAs for pancreatic cancer","volume":"8","author":"Lei","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.biopha.2026.119394_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24546","article-title":"Long non-coding RNA MIR600HG as a ceRNA inhibits the pancreatic cancer progression through regulating the miR-1197\/PITPNM3 axis","volume":"10","author":"Yang","year":"2024","journal-title":"Heliyon"},{"issue":"APR","key":"10.1016\/j.biopha.2026.119394_bib99","article-title":"The function and mechanism of long non-coding RNA-ATB in cancers","volume":"9","author":"Xiao","year":"2018","journal-title":"Front Physiol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119394_bib100","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1158\/1535-7163.MCT-16-0008","article-title":"Long noncoding RNA MALAT1 promotes aggressive pancreatic cancer proliferation and metastasis via the stimulation of autophagy","volume":"15","author":"Li","year":"2016","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib101","first-page":"1","article-title":"The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119394_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1004212","article-title":"LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer","volume":"12","author":"Song","year":"2022","journal-title":"Front Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119394_bib103","first-page":"3204","article-title":"EZH2-mediated H3K27me3 enrichment on the lncRNA MEG3 promoter regulates the growth and metastasis of glioma cells by regulating miR-21-3p","volume":"24","author":"Qin","year":"2020","journal-title":"Eur. Rev. Med Pharm. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119394_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189153","article-title":"Small non-coding RNAs and pancreatic ductal adenocarcinoma: Linking diagnosis, pathogenesis, drug resistance, and therapeutic potential","volume":"1879","author":"Fuller","year":"2024","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews Cancer"},{"issue":"24","key":"10.1016\/j.biopha.2026.119394_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11247310","article-title":"A Novel PiRNA Enhances CA19-9 Sensitivity for Pancreatic Cancer Identification by Liquid Biopsy","volume":"11","author":"Li","year":"2022","journal-title":"J. Clin. Med"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib106","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1053\/j.gastro.2017.03.050","article-title":"Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice","volume":"153","author":"Cui","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2026.119394_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00389","article-title":"An Emerging Class of Long Non-coding RNA With Oncogenic Role Arises From the snoRNA Host Genes","volume":"10","author":"Zimta","year":"2020","journal-title":"Front Oncol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119394_bib108","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1172\/JCI88069","article-title":"Rpl13a small nucleolar RNAs regulate systemic glucose metabolism","volume":"126","author":"Lee","year":"2016","journal-title":"J. Clin. Invest"},{"issue":"6","key":"10.1016\/j.biopha.2026.119394_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/br.2024.1874","article-title":"Correlating tissue and plasma-specific piRNA changes to predict their possible role in pancreatic malignancy and chronic inflammation","volume":"21","author":"Saha","year":"2024","journal-title":"Biomed. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2026.119394_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051252","article-title":"The Clinical Significance of PIWIL3 and PIWIL4 Expression in Pancreatic Cancer","volume":"9","author":"Li","year":"2020","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.biopha.2026.119394_bib111","first-page":"3104","article-title":"Expression profile of tRNA-derived fragments in pancreatic cancer","volume":"18","author":"Jin","year":"2019","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.biopha.2026.119394_bib112","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00109-022-02189-0","article-title":"Extracellular vesicles-associated tRNA-derived fragments (tRFs): biogenesis, biological functions, and their role as potential biomarkers in human diseases","volume":"100","author":"Weng","year":"2022","journal-title":"J. Mol. Med."},{"issue":"3","key":"10.1016\/j.biopha.2026.119394_bib113","first-page":"837","article-title":"Serum tRNA-derived small RNAs as potential novel diagnostic biomarkers for pancreatic ductal adenocarcinoma","volume":"11","author":"Xue","year":"2021","journal-title":"Am. J. Cancer Res"},{"issue":"8","key":"10.1016\/j.biopha.2026.119394_bib114","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1261\/rna.066126.118","article-title":"tRNA fragments (tRFs) guide Ago to regulate gene expression post-transcriptionally in a Dicer-independent manner","volume":"24","author":"Kuscu","year":"2018","journal-title":"RNA"},{"issue":"16","key":"10.1016\/j.biopha.2026.119394_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21165682","article-title":"YRNAs and YRNA-Derived Fragments as New Players in Cancer Research and Their Potential Role in Diagnostics","volume":"21","author":"Guglas","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119394_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069090","article-title":"miR-19a: An Effective Regulator of SOCS3 and Enhancer of JAK-STAT Signalling","volume":"8","author":"Collins","year":"2013","journal-title":"PLoS One"},{"issue":"7592","key":"10.1016\/j.biopha.2026.119394_bib117","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biopha.2026.119394_bib118","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bbadis.2009.02.013","article-title":"miR-155 gene: A typical multifunctional microRNA","volume":"1792","author":"Faraoni","year":"2009","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"5","key":"10.1016\/j.biopha.2026.119394_bib119","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1158\/1535-7163.MCT-08-0592","article-title":"MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance","volume":"8","author":"Moriyama","year":"2009","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.biopha.2026.119394_bib120","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbrc.2013.06.097","article-title":"MiR-210 regulates the interaction between pancreatic cancer cells and stellate cells","volume":"437","author":"Takikawa","year":"2013","journal-title":"Biochem Biophys. Res Commun."},{"issue":"7291","key":"10.1016\/j.biopha.2026.119394_bib121","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08975","article-title":"Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis","volume":"464","author":"Gupta","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119394_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.765216","article-title":"Long Noncoding Competing Endogenous RNA Networks in Pancreatic Cancer","volume":"11","author":"Xiong","year":"2021","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib123","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12935-020-01715-9","article-title":"LncRNA SNHG16 contributes to tumor progression via the miR-302b-3p\/SLC2A4 axis in pancreatic adenocarcinoma","volume":"21","author":"Xu","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"4","key":"10.1016\/j.biopha.2026.119394_bib124","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.3390\/cancers2042084","article-title":"Contribution of Epithelial-Mesenchymal Transition to Pancreatic Cancer Progression","volume":"2","author":"Krantz","year":"2010","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2026.119394_bib125","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.omtn.2019.06.015","article-title":"Expression and Role of MicroRNAs from the miR-200 Family in the Tumor Formation and Metastatic Propensity of Pancreatic Cancer","volume":"17","author":"Diaz-Riascos","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"2","key":"10.1016\/j.biopha.2026.119394_bib126","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00204-021-03196-9","article-title":"Role of microRNAs in response to cadmium chloride in pancreatic ductal adenocarcinoma","volume":"96","author":"Mortoglou","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biopha.2026.119394_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1499111","article-title":"MicroRNAs in pancreatic cancer drug resistance: mechanisms and therapeutic potential","volume":"12","author":"Dong","year":"2025","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2026.119394_bib128","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/978-981-10-1498-7_14","article-title":"Viral noncoding RNAs in cancer biology","volume":"927","author":"Li","year":"2016","journal-title":"Adv. Exp. Med Biol."},{"issue":"18","key":"10.1016\/j.biopha.2026.119394_bib129","doi-asserted-by":"crossref","first-page":"25408","DOI":"10.18632\/oncotarget.8323","article-title":"Salivary HOTAIR and PVT1 as novel biomarkers for early pancreatic cancer","volume":"7","author":"Xie","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/21541264.2021.1922071","article-title":"Long noncoding RNAs: role and contribution in pancreatic cancer","volume":"12","author":"Ramya Devi","year":"2021","journal-title":"Transcription"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib131","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-023-01749-3","article-title":"The epigenetic regulatory mechanism of PIWI\/piRNAs in human cancers","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib132","article-title":"Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinoma","volume":"32","author":"Yuen","year":"2024","journal-title":"Mol. Ther. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib133","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13578-018-0202-x","article-title":"Characterization and selective incorporation of small non-coding RNAs in non-small cell lung cancer extracellular vesicles","volume":"8","author":"Li","year":"2018","journal-title":"Cell & Biosci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib134","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2407-14-85","article-title":"MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell","volume":"14","author":"Lu","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2026.119394_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115601","article-title":"Long non-coding RNAs and pancreatic cancer: A multifaceted view","volume":"167","author":"Bin Wang","year":"2023","journal-title":"Biomed. & Pharmacother."},{"issue":"48","key":"10.1016\/j.biopha.2026.119394_bib136","doi-asserted-by":"crossref","first-page":"47872","DOI":"10.1021\/acsomega.4c08947","article-title":"miR-210 Mediated Hypoxic Responses in Pancreatic Ductal Adenocarcinoma","volume":"9","author":"Mortoglou","year":"2024","journal-title":"ACS Omega"},{"issue":"7","key":"10.1016\/j.biopha.2026.119394_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101090","article-title":"Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy","volume":"14","author":"Mortoglou","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.biopha.2026.119394_bib138","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semcancer.2025.03.002","article-title":"The relationship of the microbiome, associated metabolites and the gut barrier with pancreatic cancer","volume":"112","author":"Daniel","year":"2025","journal-title":"Semin Cancer Biol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119394_bib139","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00432-021-03567-w","article-title":"Bi-direction effects between microbiome and MiRNAs in carcinogenesis","volume":"147","author":"Wang","year":"2021","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"17","key":"10.1016\/j.biopha.2026.119394_bib140","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12175643","article-title":"Microbiome and MicroRNA or Long Non-Coding RNA-Two Modern Approaches to Understanding Pancreatic Ductal Adenocarcinoma","volume":"12","author":"Izdebska","year":"2023","journal-title":"J. Clin. Med"},{"issue":"3","key":"10.1016\/j.biopha.2026.119394_bib141","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00205-17","article-title":"Interaction between Host MicroRNAs and the Gut Microbiota in Colorectal Cancer","volume":"3","author":"Yuan","year":"2018","journal-title":"mSystems"},{"issue":"8","key":"10.1016\/j.biopha.2026.119394_bib142","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1136\/gutjnl-2020-321187","article-title":"Exosomes derived from Fusobacterium nucleatum-infected colorectal cancer cells facilitate tumour metastasis by selectively carrying miR-1246\/92b-3p\/27a-3p and CXCL16","volume":"70","author":"Guo","year":"2020","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.biopha.2026.119394_bib143","doi-asserted-by":"crossref","DOI":"10.3390\/nu9040331","article-title":"Engineered Resistant-Starch (ERS) Diet Shapes Colon Microbiota Profile in Parallel with the Retardation of Tumor Growth in In Vitro and In Vivo Pancreatic Cancer Models","volume":"9","author":"Panebianco","year":"2017","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom11010026","article-title":"High Levels of Prebiotic Resistant Starch in Diet Modulate a Specific Pattern of miRNAs Expression Profile Associated to a Better Overall Survival in Pancreatic Cancer","volume":"11","author":"Trivieri","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2026.119394_bib145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-Associated Macrophages in Tumor Immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119394_bib146","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112777","article-title":"Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside","volume":"13","author":"Uddin","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"16","key":"10.1016\/j.biopha.2026.119394_bib147","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1158\/0008-5472.CAN-17-3841","article-title":"Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN\/PI3K\u03b3 to Promote Pancreatic Cancer Metastasis","volume":"78","author":"Wang","year":"2018","journal-title":"Cancer Res"},{"issue":"18","key":"10.1016\/j.biopha.2026.119394_bib148","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1158\/0008-5472.CAN-18-0124","article-title":"Transfer of miRNA in Macrophage-Derived Exosomes Induces Drug Resistance in Pancreatic Adenocarcinoma","volume":"78","author":"Binenbaum","year":"2018","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib149","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-019-1313-x","article-title":"Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-\u03b2 signaling pathway","volume":"38","author":"Yin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2026.119394_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111590","article-title":"Macrophage-derived exosomal microRNAs promote metastasis in pancreatic ductal adenocarcinoma","volume":"129","author":"Chen","year":"2024","journal-title":"Int Immunopharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119394_bib151","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092415","article-title":"The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness","volume":"10","author":"Ma","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib152","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.canlet.2014.01.020","article-title":"MicroRNA Let-7 Downregulates STAT3 Phosphorylation in Pancreatic Cancer Cells by Increasing SOCS3 Expression","volume":"347","author":"Patel","year":"2014","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.biopha.2026.119394_bib153","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11112874","article-title":"MiR-506 Promotes Antitumor Immune Response in Pancreatic Cancer by Reprogramming Tumor-Associated Macrophages toward an M1 Phenotype","volume":"11","author":"Yang","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.biopha.2026.119394_bib154","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1158\/0008-5472.CAN-07-5714","article-title":"Cancer-associated stromal fibroblasts promote pancreatic tumor progression","volume":"68","author":"Hwang","year":"2008","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.biopha.2026.119394_bib155","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20192358","article-title":"MiR-760 enhances sensitivity of pancreatic cancer cells to gemcitabine through modulating Integrin \u03b21","volume":"39","author":"Yang","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.biopha.2026.119394_bib156","doi-asserted-by":"crossref","DOI":"10.1038\/srep11450","article-title":"Pathophysiological role of microRNA-29 in pancreatic cancer stroma","volume":"5","author":"Kwon","year":"2015","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2026.119394_bib157","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3727\/096504017X14934840662335","article-title":"Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer","volume":"26","author":"Zhang","year":"2018","journal-title":"Oncol. Res"},{"issue":"4","key":"10.1016\/j.biopha.2026.119394_bib158","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00280-024-04712-1","article-title":"Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinoma","volume":"94","author":"Sousa","year":"2024","journal-title":"Cancer Chemother. Pharm."},{"issue":"11","key":"10.1016\/j.biopha.2026.119394_bib159","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14112812","article-title":"Cancer-Associated Fibroblasts Confer Gemcitabine Resistance to Pancreatic Cancer Cells through PTEN-Targeting miRNAs in Exosomes","volume":"14","author":"Richards","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2026.119394_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100960","article-title":"Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs","volume":"68","author":"Qi","year":"2023","journal-title":"Drug Resist Updat"},{"issue":"2","key":"10.1016\/j.biopha.2026.119394_bib161","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.21037\/jgo-23-198","article-title":"Exosomal miR-125b-5p derived from cancer-associated fibroblasts promotes the growth, migration, and invasion of pancreatic cancer cells by decreasing adenomatous polyposis coli (APC) expression","volume":"14","author":"Guo","year":"2023","journal-title":"J. Gastrointest. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib162","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/15384047.2022.2041961","article-title":"Carcinoma-associated fibroblasts release microRNA-331-3p containing extracellular vesicles to exacerbate the development of pancreatic cancer via the SCARA5-FAK axis","volume":"23","author":"Han","year":"2022","journal-title":"Cancer Biol. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2026.119394_bib163","first-page":"663","article-title":"MicroRNAs in stool samples as potential screening biomarkers for pancreatic ductal adenocarcinoma cancer","volume":"4","author":"Yang","year":"2014","journal-title":"Am. J. Cancer Res"},{"issue":"3","key":"10.1016\/j.biopha.2026.119394_bib164","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s12029-022-00877-1","article-title":"Circulating MicroRNAs as Noninvasive Diagnostic and Prognostic Biomarkers in Pancreatic Cancer: A Review","volume":"54","author":"Khan","year":"2023","journal-title":"J. Gastrointest. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2026.119394_bib165","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12094-021-02708-4","article-title":"Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines","volume":"24","author":"Garc\u00eda-Alfonso","year":"2022","journal-title":"Clin. Transl. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib166","doi-asserted-by":"crossref","DOI":"10.1080\/08941939.2023.2216756","article-title":"Expression of miR-425-5p in Pancreatic Carcinoma and Its Correlation with Tumor Immune Microenvironment","volume":"36","author":"Jian","year":"2023","journal-title":"J. Invest Surg."},{"issue":"2","key":"10.1016\/j.biopha.2026.119394_bib167","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1053\/j.gastro.2020.04.057","article-title":"A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases","volume":"159","author":"Nishiwada","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib168","doi-asserted-by":"crossref","DOI":"10.1093\/pcmedi\/pbad004","article-title":"Dysregulated miRNAs modulate tumor microenvironment associated signaling networks in pancreatic ductal adenocarcinoma","volume":"6","author":"Liu","year":"2023","journal-title":"Precis Clin. Med"},{"key":"10.1016\/j.biopha.2026.119394_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115601","article-title":"Long non-coding RNAs and pancreatic cancer: A multifaceted view","volume":"167","author":"Bin Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.biopha.2026.119394_bib170","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/CM9.0000000000003587","article-title":"Role of noncoding RNA and protein interaction in pancreatic cancer","volume":"138","author":"Li","year":"2025","journal-title":"Chin. Med J."},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib171","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12943-025-02254-5","article-title":"Role of circular RNAs in cancer therapy resistance","volume":"24","author":"Liu","year":"2025","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.biopha.2026.119394_bib172","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.drudis.2022.05.012","article-title":"Long noncoding RNAs (lncRNAs) in pancreatic cancer progression","volume":"27","author":"Ashrafizadeh","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib173","doi-asserted-by":"crossref","DOI":"10.1038\/cddiscovery.2017.4","article-title":"Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer cells","volume":"3","author":"Fu","year":"2017","journal-title":"Cell Death Discov."},{"issue":"2","key":"10.1016\/j.biopha.2026.119394_bib174","first-page":"1093","article-title":"Long non-coding RNA PVT1 promotes epithelial-mesenchymal transition via the TGF-\u03b2\/Smad pathway in pancreatic cancer cells","volume":"40","author":"Zhang","year":"2018","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib175","doi-asserted-by":"crossref","DOI":"10.1007\/s10565-024-09863-8","article-title":"MKLN1-AS promotes pancreatic cancer progression as a crucial downstream mediator of HIF-1\u03b1 through miR-185-5p\/TEAD1 pathway","volume":"40","author":"Chen","year":"2024","journal-title":"Cell Biol. Toxicol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119394_bib176","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41419-017-0052-1","article-title":"FEZF1-AS1\/miR-107\/ZNF312B axis facilitates progression and Warburg effect in pancreatic ductal adenocarcinoma","volume":"9","author":"Ye","year":"2018","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.biopha.2026.119394_bib177","first-page":"2212","article-title":"Long non-coding RNA HOTAIR promotes cancer cell energy metabolism in pancreatic adenocarcinoma by upregulating hexokinase-2","volume":"18","author":"Ma","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2026.119394_bib178","article-title":"Diagnostic and prognostic role of circRNAs in pancreatic cancer: a meta-analysis","volume":"13","author":"Zhao","year":"2023","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib179","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-021-01400-z","article-title":"Circular RNA CircEYA3 induces energy production to promote pancreatic ductal adenocarcinoma progression through the miR-1294\/c-Myc axis","volume":"20","author":"Rong","year":"2021","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib180","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-020-01196-4","article-title":"Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p\/MET\/Akt axis","volume":"19","author":"Guo","year":"2020","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.biopha.2026.119394_bib181","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-024-07138-y","article-title":"cNEK6 induces gemcitabine resistance by promoting glycolysis in pancreatic ductal adenocarcinoma via the SNRPA\/PPA2c\/mTORC1 axis","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib182","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12943-023-01923-7","article-title":"Role of a novel circRNA-CGNL1 in regulating pancreatic cancer progression via NUDT4\u2013HDAC4\u2013RUNX2\u2013GAMT-mediated apoptosis","volume":"23","author":"Yuan","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2026.119394_bib183","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1517154","article-title":"Microbial dysbiosis in periodontitis and peri-implantitis: pathogenesis, immune responses, and therapeutic","volume":"15","author":"Cui","year":"2025","journal-title":"Front Cell Infect. Microbiol"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib184","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10010186","article-title":"Oral Microbiome, Oral Health and Systemic Health: A Multidirectional Link","volume":"10","author":"Varoni","year":"2022","journal-title":"Biomedicines"},{"issue":"10","key":"10.1016\/j.biopha.2026.119394_bib185","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1177\/00220345241263768","article-title":"Association between Periodontal Diseases and the Risk of Site-Specific Gastrointestinal Cancers: A Systematic Review and Meta-Analysis","volume":"103","author":"Wang","year":"2024","journal-title":"J. Dent. Res"},{"issue":"5","key":"10.1016\/j.biopha.2026.119394_bib186","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/annonc\/mdx019","article-title":"Periodontal disease, edentulism, and pancreatic cancer: a meta-analysis","volume":"28","author":"Maisonneuve","year":"2017","journal-title":"Ann. Oncol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119394_bib187","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3390\/pathogens14121233","article-title":"Oral Microbiota and Carcinogenesis: Exploring the Systemic Impact of Oral Pathogens","volume":"14","author":"Nikoli\u0107","year":"2025","journal-title":"Pathogens"},{"issue":"5","key":"10.1016\/j.biopha.2026.119394_bib188","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/gutjnl-2023-330941","article-title":"Oral bacteria accelerate pancreatic cancer development in mice","volume":"73","author":"Saba","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2026.119394_bib189","article-title":"Interplay of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans along with Circulating miR-21 and miR-155 as Potential Biomarkers for Pancreatic Cancer","author":"Hesami","year":"2025","journal-title":"bioRxiv"},{"issue":"3","key":"10.1016\/j.biopha.2026.119394_bib190","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.21873\/invivo.13944","article-title":"Identification of Common miRNAs Differentially Expressed in Periodontitis and Pancreatic Cancer","volume":"39","author":"Sunnetci-Akkoyunlu","year":"2025","journal-title":"Vivo"},{"key":"10.1016\/j.biopha.2026.119394_bib191","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1678114","article-title":"Integrated periodontal pathogens and circulating miRNAs: a novel non-invasive panel of biomarkers for pancreatic cancer","volume":"15","author":"Hesami","year":"2025","journal-title":"Front Cell Infect. Microbiol"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib192","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-025-03612-8","article-title":"Evaluating topography of mutational signatures with SigProfilerTopography","volume":"26","author":"Otlu","year":"2025","journal-title":"Genome Biol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119394_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112930","article-title":"Topography of mutational signatures in human cancer","volume":"42","author":"Otlu","year":"2023","journal-title":"Cell Rep."},{"issue":"7793","key":"10.1016\/j.biopha.2026.119394_bib194","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-cancer analysis of whole genomes","volume":"578","author":"Campbell","year":"2020","journal-title":"Nature"},{"issue":"7793","key":"10.1016\/j.biopha.2026.119394_bib195","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biopha.2026.119394_bib196","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005217","article-title":"Disruption of Transcriptional Coactivator Sub1 Leads to Genome-Wide Re-distribution of Clustered Mutations Induced by APOBEC in Active Yeast Genes","volume":"11","author":"Lada","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.biopha.2026.119394_bib197","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.canlet.2018.06.015","article-title":"Loss of Linc01060 induces pancreatic cancer progression through vinculin-mediated focal adhesion turnover","volume":"433","author":"Shi","year":"2018","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib198","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2023.2198904","article-title":"LINC01060 knockdown inhibits osteosarcoma cell malignant behaviors in vitro and tumor growth and metastasis in vivo through the PI3K\/Akt signaling","volume":"24","author":"Zhang","year":"2023","journal-title":"Cancer Biol. Ther."},{"issue":"7","key":"10.1016\/j.biopha.2026.119394_bib199","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/s41416-024-02794-5","article-title":"Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning","volume":"131","author":"Kawai","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2026.119394_bib200","doi-asserted-by":"crossref","first-page":"713","DOI":"10.4251\/wjgo.v15.i5.713","article-title":"Intratumour microbiome of pancreatic cancer","volume":"15","author":"Guan","year":"2023","journal-title":"World J. Gastrointest. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib201","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12967-025-06128-8","article-title":"Long non-coding RNA MIR4435-2HG modulates pancreatic cancer stem cells and chemosensitivity to gemcitabine by targeting the miR-1252-5p\/STAT1","volume":"23","author":"Xie","year":"2025","journal-title":"J. Transl. Med"},{"issue":"11","key":"10.1016\/j.biopha.2026.119394_bib202","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-04293-4","article-title":"Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4\/MyD88\/AKT\/NF-\u03baB pathway in pancreatic cancer","volume":"12","author":"Yin","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib203","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-020-01153-1","article-title":"lncRNA-PLACT1 sustains activation of NF-\u03baB pathway through a positive feedback loop with I\u03baB\u03b1\/E2F1 axis in pancreatic cancer","volume":"19","author":"Ren","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib204","article-title":"Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinoma","volume":"32","author":"Yuen","year":"2024","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.biopha.2026.119394_bib205","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2026.150063","article-title":"Emerging roles of non-coding RNAs in the tumor microenvironment of pancreatic cancer: Focusing on current challenges and future directions","volume":"988","author":"Cui","year":"2026","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.biopha.2026.119394_bib206","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030290","article-title":"Cancer-Associated Fibroblasts\u2019 Functional Heterogeneity in Pancreatic Ductal Adenocarcinoma","volume":"11","author":"Awaji","year":"2019","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.biopha.2026.119394_bib207","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/j.gastro.2012.11.037","article-title":"A Starring Role for Stellate Cells in the Pancreatic Cancer Microenvironment","volume":"144","author":"Apte","year":"2013","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.2012.569","article-title":"Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer","volume":"108","author":"Provenzano","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"13","key":"10.1016\/j.biopha.2026.119394_bib209","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/onc.2016.353","article-title":"Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells","volume":"36","author":"Richards","year":"2017","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.biopha.2026.119394_bib210","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1172\/JCI87734","article-title":"Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness","volume":"126","author":"Leca","year":"2016","journal-title":"J. Clin. Invest"},{"issue":"6","key":"10.1016\/j.biopha.2026.119394_bib211","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib212","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1038\/s41467-018-05906-x","article-title":"Reversal of pancreatic desmoplasia by re-educating stellate cells with a tumour microenvironment-activated nanosystem","volume":"9","author":"Han","year":"2018","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.biopha.2026.119394_bib213","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.21873\/anticanres.13026","article-title":"Targeted Therapies for Pancreatic Cancer and Hurdles Ahead","volume":"38","author":"Aslan","year":"2018","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.biopha.2026.119394_bib214","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1124\/jpet.118.255786","article-title":"Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer","volume":"370","author":"Lei","year":"2019","journal-title":"J. Pharm. Exp. Ther."},{"issue":"29","key":"10.1016\/j.biopha.2026.119394_bib215","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202400485","article-title":"Bispecific, Exosome-Mimetic Lipid Nanoparticles Facilitate Dual siRNAs for Synergistic Therapy against Pancreatic Cancer","volume":"34","author":"Wang","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biopha.2026.119394_bib216","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.actbio.2023.05.043","article-title":"Overcoming tumor microenvironment obstacles: Current approaches for boosting nanodrug delivery","volume":"166","author":"Wang","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2026.119394_bib217","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jconrel.2015.08.017","article-title":"Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors","volume":"219","author":"Miao","year":"2015","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.biopha.2026.119394_bib218","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1021\/acs.molpharmaceut.4c00329","article-title":"Breaking Down Barriers in Drug Delivery by Stromal Remodeling Approaches in Pancreatic Cancer","volume":"21","author":"Zhou","year":"2024","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2026.119394_bib219","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"27","key":"10.1016\/j.biopha.2026.119394_bib220","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7571","key":"10.1016\/j.biopha.2026.119394_bib221","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature15373","article-title":"Nanoparticle biointerfacing by platelet membrane cloaking","volume":"526","author":"Hu","year":"2015","journal-title":"Nature"},{"issue":"7291","key":"10.1016\/j.biopha.2026.119394_bib222","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature08956","article-title":"Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles","volume":"464","author":"Davis","year":"2010","journal-title":"Nature"},{"issue":"51","key":"10.1016\/j.biopha.2026.119394_bib223","doi-asserted-by":"crossref","first-page":"20723","DOI":"10.1073\/pnas.1314307110","article-title":"Mutant KRAS is a druggable target for pancreatic cancer","volume":"110","author":"Khvalevsky","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.biopha.2026.119394_bib224","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10637-016-0407-y","article-title":"Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors","volume":"35","author":"Beg","year":"2017","journal-title":"Invest N. Drugs"},{"issue":"6","key":"10.1016\/j.biopha.2026.119394_bib225","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.juro.2013.12.011","article-title":"DNA based therapy with diphtheria toxin-A BC-819: a phase 2b marker lesion trial in patients with intermediate risk nonmuscle invasive bladder cancer","volume":"191","author":"Gofrit","year":"2014","journal-title":"J. Urol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119394_bib226","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2026.119394_bib227","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41416-022-02123-8","article-title":"Synthetic miR-34a against solid tumours: a predictable failure","volume":"128","author":"Mockly","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib228","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1582-4934.2008.00556.x","article-title":"miR-21: a small multi-faceted RNA","volume":"13","author":"Krichevsky","year":"2009","journal-title":"J. Cell Mol. Med"},{"issue":"10","key":"10.1016\/j.biopha.2026.119394_bib229","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf309","article-title":"Prognostic value of miR-21 in colorectal cancer, pancreatic ductal adenocarcinoma, and esophageal squamous cell carcinoma: updated systematic review and meta-analysis","volume":"30","author":"Huang","year":"2025","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib230","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/modpathol.2011.142","article-title":"Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma","volume":"25","author":"Nagao","year":"2012","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.biopha.2026.119394_bib231","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1457875","article-title":"MicroRNAs: emerging biomarkers and therapeutic targets in pancreatic cancer","volume":"11","author":"Yuan","year":"2024","journal-title":"Front Mol. Biosci."},{"issue":"22","key":"10.1016\/j.biopha.2026.119394_bib232","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1158\/0008-5472.CAN-13-1288","article-title":"Targeting microRNAs in pancreatic cancer: Microplayers in the big game","volume":"73","author":"Khan","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2026.119394_bib233","article-title":"Preclinical Screening of Splice-Switching Antisense Oligonucleotides in PDAC Organoids","author":"Wan","year":"2023","journal-title":"bioRxiv"},{"issue":"3","key":"10.1016\/j.biopha.2026.119394_bib234","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1158\/0008-5472.CAN-12-2850","article-title":"The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells","volume":"73","author":"Gutschner","year":"2013","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.biopha.2026.119394_bib235","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/nar\/gkv1206","article-title":"Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides","volume":"44","author":"Lennox","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.biopha.2026.119394_bib236","article-title":"Expression Profiling Identifies the Noncoding Processed Transcript of HNRNPU with Proliferative Properties in Pancreatic Ductal Adenocarcinoma","volume":"3","author":"Sutaria","year":"2017","journal-title":"Noncoding RNA"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib237","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/hum.2018.063","article-title":"Application of CRISPR-Cas9 for Long Noncoding RNA Genes in Cancer Research","volume":"30","author":"Zhen","year":"2019","journal-title":"Hum. Gene Ther."},{"issue":"5","key":"10.1016\/j.biopha.2026.119394_bib238","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051227","article-title":"LINC00261 Is Differentially Expressed in Pancreatic Cancer Subtypes and Regulates a Pro-Epithelial Cell Identity","volume":"12","author":"Dorn","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.biopha.2026.119394_bib239","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/cgt.2012.10","article-title":"Phase 1\/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer","volume":"19","author":"Hanna","year":"2012","journal-title":"Cancer Gene Ther."},{"issue":"11","key":"10.1016\/j.biopha.2026.119394_bib240","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3390\/biom11111665","article-title":"LncRNAs: Novel Biomarkers for Pancreatic Cancer","volume":"11","author":"Ghafouri-Fard","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2026.119394_bib241","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1355064","article-title":"The roles of lncRNAs and miRNAs in pancreatic cancer: a focus on cancer development and progression and their roles as potential biomarkers","volume":"14","author":"Jafari","year":"2024","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2026.119394_bib242","doi-asserted-by":"crossref","unstructured":"What will it take to get miRNA therapies to market? Nat Biotechnol. 2024 Nov 1;42(11):1623\u20131624. doi:10.1038\/S41587-024-02480-0;KWRD PubMed PMID: 39496928.","DOI":"10.1038\/s41587-024-02480-0"},{"issue":"15_","key":"10.1016\/j.biopha.2026.119394_bib243","article-title":"A phase I trial of a local delivery of siRNA against k-ras in combination with chemotherapy for locally advanced pancreatic adenocarcinoma","volume":"31","author":"Golan","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119394_bib244","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00018-017-2656-0","article-title":"Evaluation and control of miRNA-like off-target repression for RNA interference","volume":"75","author":"Seok","year":"2017","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.biopha.2026.119394_bib245","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117557","article-title":"An insight into allele-selective approaches to lowering mutant huntingtin protein for Huntington\u2019s disease treatment","volume":"180","author":"Yao","year":"2024","journal-title":"Biomed. & Pharmacother."},{"issue":"15_","key":"10.1016\/j.biopha.2026.119394_bib246","article-title":"MRX34, a liposomal miR-34 mimic and potential first-in-class microRNA therapeutic: activity in animal models of liver cancer","volume":"34","author":"Daige","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119394_bib247","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101638","article-title":"RNAi-Based Approaches for Pancreatic Cancer Therapy","volume":"13","author":"Kim","year":"2021","journal-title":"Pharmaceutics"},{"issue":"27","key":"10.1016\/j.biopha.2026.119394_bib248","doi-asserted-by":"crossref","first-page":"24560","DOI":"10.18632\/oncotarget.4183","article-title":"RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients","volume":"6","author":"Golan","year":"2015","journal-title":"Oncotarget"},{"issue":"36","key":"10.1016\/j.biopha.2026.119394_bib249","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1200\/JCO.2013.55.0376","article-title":"First-in-human phase I study of the liposomal RNA interference therapeutic Atu027 in patients with advanced solid tumors","volume":"32","author":"Schultheis","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119394_bib250","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.amjsurg.2017.03.049","article-title":"MicroRNA-21 as a prognostic biomarker in patients with pancreatic cancer \u2013 A systematic review and meta-analysis","volume":"214","author":"Negoi","year":"2017","journal-title":"Am. J. Surg."},{"issue":"2","key":"10.1016\/j.biopha.2026.119394_bib251","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1159\/000495328","article-title":"miRNA-1290 Promotes Aggressiveness in Pancreatic Ductal Adenocarcinoma by Targeting IKK1","volume":"51","author":"Ta","year":"2018","journal-title":"Cell Physiol. Biochem"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib252","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/CM9.0000000000001826","article-title":"MicroRNAs as potential therapeutic targets for pancreatic cancer","volume":"135","author":"Chu","year":"2021","journal-title":"Chin. Med J. (Engl. )"},{"issue":"16","key":"10.1016\/j.biopha.2026.119394_bib253","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164161","article-title":"Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs","volume":"13","author":"Li","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"27","key":"10.1016\/j.biopha.2026.119394_bib254","doi-asserted-by":"crossref","first-page":"23323","DOI":"10.18632\/oncotarget.4492","article-title":"MicroRNA in pancreatic adenocarcinoma: predictive\/prognostic biomarkers or therapeutic targets?","volume":"6","author":"Brunetti","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.biopha.2026.119394_bib255","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/CM9.0000000000001826","article-title":"MicroRNAs as potential therapeutic targets for pancreatic cancer","volume":"135","author":"Chu","year":"2022","journal-title":"Chin. Med J."},{"issue":"8056","key":"10.1016\/j.biopha.2026.119394_bib256","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41586-024-08508-4","article-title":"RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer","volume":"639","author":"Sethna","year":"2025","journal-title":"Nature"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226004294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226004294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:45:46Z","timestamp":1794476746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226004294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":256,"alternative-id":["S0753332226004294"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119394","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-coding RNAs as biomarkers and therapeutic targets in pancreatic cancer: Clinical implications and translational perspectives","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119394"}}